Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB26FUMAL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,124
Award facts
- Contract value 100% obligated
- $38,124.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded November 12, 2025, covers the supply of RINVOQ ER 45 mg tablets (28-count units) to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was competitively awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with a ceiling value of approximately $38.1K. The award employs firm fixed pricing with an ultimate completion date of November 13, 2025, and carries no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million and extending through December 2026, which serves as the primary vehicle for pharmaceutical procurement to support military healthcare systems globally.
AmerisourceBergen's role as a prime vendor under the DLA Troop Support Medical contract reflects its established capability to supply a comprehensive range of pharmaceutical products and medical commodities across multiple therapeutic domains to Defense Health Agency customers and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates consistent performance in delivering both brand-name and generic medications through competitive procurement processes. This specific delivery order for RINVOQ ER tablets represents the type of targeted pharmaceutical procurement executed under the broader IDC framework, supporting the DLA's mission to provide critical medical supplies to military personnel and veterans across global operations.
Quick answers
Who was awarded contract SPE2DB26FUMAL?
SPE2DB26FUMAL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FUMAL worth?
The government has obligated $38,124 on SPE2DB26FUMAL.
Is contract SPE2DB26FUMAL an order under another contract?
Yes. SPE2DB26FUMAL is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB26FUMAL competed?
The extent of competition for SPE2DB26FUMAL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award